Sub-Saharan Africa is disproportionately affected by infectious diseases. HIV/AIDS, Malaria and Tuberculosis are the leading cause of death among pregnant women and children less than five years. In recent times however, disease like cholera which has assumed an endemic status in this region resulted in death of significant proportion of the population. In controlling these diseases, advances in diagnostic, preventive and management methods has been introduced. This recent technological developments have led to the proliferation of new, rapid diagnostic tests and candidate vaccines. However, the usefulness of this novel method in a given setting and the choice of its appropriateness are in doubt necessitating a need to evaluate these tools in laboratory, clinical or field settings. For example since the development of oral vaccine for cholera its efficacy and effectiveness is yet to be determined in control of cholera epidemic in Sub- Saharan Africa. Base on this premise, I believe there is a lack of resources and expertise in many developing countries to perform adequate evaluations of these new tests and candidate vaccines that are usually marketed directly to end-users. Therefore, there is a need for capacity building through the distance learning MSc in Clinical Trial.